A detailed history of Capital Advisors, Ltd. LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 14,365 shares of PFE stock, worth $383,832. This represents 0.05% of its overall portfolio holdings.

Number of Shares
14,365
Previous 14,363 0.01%
Holding current value
$383,832
Previous $402,000 3.48%
% of portfolio
0.05%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$27.7 - $31.39 $55 - $62
2 Added 0.01%
14,365 $416,000
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $10,912 - $12,787
-432 Reduced 2.92%
14,363 $402,000
Q1 2024

Apr 18, 2024

SELL
$25.89 - $29.73 $1,061 - $1,218
-41 Reduced 0.28%
14,795 $411,000
Q4 2023

Feb 02, 2024

BUY
$26.13 - $33.94 $25,555 - $33,193
978 Added 7.06%
14,836 $427,000
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $14,857 - $17,367
-463 Reduced 3.23%
13,858 $460,000
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $112,405 - $130,050
3,112 Added 27.76%
14,321 $525,000
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $28,400 - $36,972
721 Added 6.87%
11,209 $457,000
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $13,234 - $17,276
317 Added 3.12%
10,488 $537,000
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $1,837 - $2,243
-42 Reduced 0.41%
10,171 $445,000
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $3,396 - $4,027
73 Added 0.72%
10,213 $535,000
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $67,161 - $83,220
-1,468 Reduced 12.65%
10,140 $525,000
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $32,890 - $48,755
796 Added 7.36%
11,608 $685,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $13,109 - $16,840
334 Added 3.19%
10,812 $465,000
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $15,028 - $19,109
-449 Reduced 4.11%
10,478 $386,000
Q3 2020

Nov 03, 2020

BUY
$31.75 - $37.25 $31 - $37
1 Added 0.01%
10,927 $401,000
Q2 2020

Aug 06, 2020

BUY
$30.12 - $36.54 $30 - $36
1 Added 0.01%
10,926 $357,000
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $4,973 - $7,106
184 Added 1.71%
10,925 $357,000
Q4 2019

Feb 03, 2020

BUY
$32.92 - $37.36 $44,145 - $50,099
1,341 Added 14.27%
10,741 $421,000
Q3 2019

Oct 23, 2019

SELL
$32.49 - $42.13 $47,987 - $62,226
-1,477 Reduced 13.58%
9,400 $338,000
Q2 2019

Jul 31, 2019

SELL
$36.98 - $41.52 $147,735 - $165,872
-3,995 Reduced 26.86%
10,877 $471,000
Q4 2018

Jan 29, 2019

BUY
$38.47 - $43.86 $38 - $43
1 Added 0.01%
14,872 $649,000
Q3 2018

Oct 24, 2018

BUY
$34.47 - $41.81 $123,092 - $149,303
3,571 Added 31.6%
14,871 $655,000
Q2 2018

Jul 20, 2018

BUY
$32.98 - $35.16 $32 - $35
1 Added 0.01%
11,300 $410,000
Q1 2018

Apr 23, 2018

BUY
$31.91 - $37.02 $31 - $37
1 Added 0.01%
11,299 $401,000
Q4 2017

Jan 16, 2018

BUY
$33.26 - $35.29 $33 - $35
1 Added 0.01%
11,298 $409,000
Q3 2017

Oct 25, 2017

BUY
$31.0 - $34.15 $350,207 - $385,792
11,297
11,297 $403,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.